Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00641238 · ClinicalTrials.gov registry record
Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 20
- Enrollment target
NCT00641238 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 20 participants.
The verdict
NCT00641238 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
We are collecting clinical notes and results of imaging studies (CT and PET scans) from referring physicians who follow the clinical status of patients treated with radiofrequency ablation (RFA). The research objective is to determine whether the patients with (RFA) remain alive, and whether they are in remission or have progressive/ recurrent malignancy
Interventions
- DEVICE Radiofrequency ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-03 |
| Est. Completion | 2011-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00641238
The ClinicalTrials.gov registry entry for NCT00641238 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiofrequency ablation is the first listed.
NCT00641238 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00641238 about?
NCT00641238 is a clinical study titled "Outcome of Patients With Lung Masses Who Are Treated With Radiofrequency Ablation (RFA)". We are collecting clinical notes and results of imaging studies (CT and PET scans) from referring physicians who follow the clinical status of patients treated with radiofrequency ablation (RFA). The research objective is to determine whether the patients with (RFA) remain alive, and whether they ar...
What is the current status of trial NCT00641238?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2004-03. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00641238?
The interventions under investigation include: Radiofrequency ablation (DEVICE).
Who is sponsoring clinical trial NCT00641238?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.